Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (4): 541-544    DOI: 10.31083/j.ejgo.2020.04.5370
Original Research Previous articles | Next articles
Is it enough in ovarian cancer staging surgery to laparoscopic surgery? Comparison of surgical methods
Jae Hong Sang1, Soo-Ho Chung1, *()
1Department of Obstetrics and Gynecology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, South of Korea
Download:  PDF(147KB)  ( 211 ) Full text   ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: This study was carried out to compare conventional laparotomy with laparoscopic surgery for ovarian cancer and identify no difference between conventional laparotomy and laparoscopic surgery for advanced ovarian cancer. Materials and Methods: Targeting 249 patients, who had been diagnosed with ovarian cancer and had undergone treatment in general university hospitals over ten years, this study was conducted with two gynecologic oncologists. The patients were placed in a laparotomy group (group 1) and a laparoscopic surgery group (including robotic surgery) (group 2). Results: One hundred ninety-two of a total of 249 patients belonged to the laparotomy group and 57 patients belonged to the laparoscopic surgery group. With regards to ovarian cancer staging, 80 of 249 (32.1%) patients were in Stage I-II and 129 of 249 patients were in Stage III-IV. Twenty of 249 (8%) patients (16 of 192 patients in group 1, 4 of 57 patients in group 2) suffered from operative complications and one great vessel injury was found in group 1. Sixty-nine of 249 patients (27.7%) [58 of 192 patients in group 1 (30.2%) and 11 of 57 patients in group 2 (19.2%)] had a relapse. In terms of the correlation between recurrence and operative methods, and risk, the hazard risk (HR) was measured at 0.552 (0.267–5.343), indicating that there was no close correlation. Conclusion: Laparoscopic surgery is not inferior to laparotomy for advanced ovarian cancer and it is therefore anticipated that laparoscopic surgery can be considered a treatment for early stage and unidentified stage ovarian cancer with low HE 4 and CA 125.
Key words:  Ovarian cancer      Laparotomy      Laparoscopy      Cancer staging     
Submitted:  12 September 2019      Accepted:  28 October 2019      Published:  15 August 2020     
Fund: 
Soonchunhyang University
*Corresponding Author(s):  SOO-HO CHUNG     E-mail:  guardc@schmc.ac.kr

Cite this article: 

Jae Hong Sang, Soo-Ho Chung. Is it enough in ovarian cancer staging surgery to laparoscopic surgery? Comparison of surgical methods. European Journal of Gynaecological Oncology, 2020, 41(4): 541-544.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.04.5370     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I4/541

[1] Silvia Ortega, José Angel Mínguez, José Manuel Aramendía, Marta Santisteban, Fernando Martinez-Regueira, Pablo Martí-Cruchaga, Juan Luis Alcázar, Matías Jurado. The impact of secondary cytoreductive surgery on survival in first recurrence of platinum sensitive epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 523-530.
[2] Sigit Purbadi, Gregorius Tanamas, Lisa Novianti. Advanced stage ovarian cancer survival in Jakarta[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 587-590.
[3] Gen-Hai Zhu, Kang Wang, Lan Hong, Xin-Hui Fu, Fu-Jin Liu, Hai-Yan Huang. Safety and efficacy of fertility-sparing surgery for an orthotopic xenograft model of epithelial ovarian cancer in nude mice[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 609-616.
[4] Xifang Lv, Amanguli, Ping Yang. The role of sodium hydrosulfide in the proliferation and apoptosis of exogenous SB203580 pre-treated human ovarian cancer cells[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 622-628.
[5] Terumi Tanigawa, Maki Matoda, Yoichi Aoki, Hidetaka Nomura, Sanshiro Okamoto, Kohei Omatsu, Hiroyuki Kanao, Nobuhiro Takeshima. A case of recurrent smooth muscle tumor of uncertain malignant potential with abdominal dissemination after morcellation[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 648-650.
[6] F. Oyama, Y. Asano, H. Shimoda, K. Horie, J. Watanabe, Y. Yokoayama. Morphological analysis of peritoneal dissemination of ovarian cancer based on levels of carbonyl reductase 1 expression[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 352-360.
[7] C.J. Heesterbeek, A.M. Thijs, R.H.M. Hermans, D. Boll, G.-J. Creemers. Bevacizumab in combination with metronomic oral cyclophosphamide: an effective and well-tolerated treatment for patients with recurrent ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 364-367.
[8] S.R Oh, J.-W. Park. Is the Risk of Malignancy Index a predictive tool for preoperative differentiation between borderline ovarian tumor and ovarian cancer?[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 368-374.
[9] T. Shoji, E. Takatori, M. Kagabu, M. Futagami, Y. Yokoyama, H. Tokunaga, N. Yaegashi, T. Ohta, T. Watanabe, T Sugiyama. Relationship between usefulness of irinotecan and pegylated liposomal doxorubicin therapy and the UGT1A1 genotype in patients with recurrent ovarian cancer (TGCU 104 study)[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 380-385.
[10] Emine Karabuk, Burak Karadag, Ceyda Karadag, M. Faruk Kose, M. Murat Naki, E. Nilufer Guler. The outcomes of fertility sparing surgery in epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 391-395.
[11] Chenchen Zhu, Hanyuan Liu, Zhen Shen, Yanhu Xie, Tianjiao Zhang, Björn Nashan, Dabao Wu, Ying Zhou. Treatment and survival outcomes from epithelial ovarian cancer in women aged 65 years or older[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 415-421.
[12] L.D. Gutierrez-Castañeda, J.F. Polo, C. Carmona, D. Sanabria, D.M. Caballero, A. Jutinico, R. Parra-Medina. Expression of heat shock protein Hsp 27 in ovarian carcinoma[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 221-226.
[13] K. Plagens–Rotman, M. Piskorz–Szymendera, B. PIĘTA. Lifestyle with particular emphasis on physical activity and genital carcinomas in women[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 233-239.
[14] Can Fang, Yan Zhao, Kezhen Li, Danhui Weng, Peng Wu, Gang Chen, Ding Ma, Juncheng Wei. Diabetes mellitus and epithelial ovarian cancer in Chinese women: a retrospective cohort study[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 260-264.
[15] X.W. Wang, J.W. Tian, L.L. Fan, R.H. Wang. The diagnostic value of color Doppler ultrasound on ovarian cancer in nude mice[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 273-276.
No Suggested Reading articles found!